APA (7th ed.) Citation

Yang, K., Chi, M., Hao, C., Ko, H., Huang, Y., Wu, R., . . . Chi, K. (2025). Phase II clinical trial assessing the addition of hyperthermia to salvage concurrent chemoradiotherapy for unresectable recurrent head and neck cancer in previously irradiated patients. Radiation Oncology, 20(1), 1. https://doi.org/10.1186/s13014-025-02585-z

Chicago Style (17th ed.) Citation

Yang, Kai-Lin, et al. "Phase II Clinical Trial Assessing the Addition of Hyperthermia to Salvage Concurrent Chemoradiotherapy for Unresectable Recurrent Head and Neck Cancer in Previously Irradiated Patients." Radiation Oncology 20, no. 1 (2025): 1. https://doi.org/10.1186/s13014-025-02585-z.

MLA (9th ed.) Citation

Yang, Kai-Lin, et al. "Phase II Clinical Trial Assessing the Addition of Hyperthermia to Salvage Concurrent Chemoradiotherapy for Unresectable Recurrent Head and Neck Cancer in Previously Irradiated Patients." Radiation Oncology, vol. 20, no. 1, 2025, p. 1, https://doi.org/10.1186/s13014-025-02585-z.